Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRI-724 in HCV/HBV Liver Cirrhosis
NCT03620474Phase 2Completed
- Start
- Jul 2018
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of foscenvivint in Liver cirrhosis (LC). Started Jul 2018; status: completed.
02
Drugs
foscenvivint
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT03620474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03620474.